On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy. Academic Article uri icon

Overview

abstract

  • Clinical Trials Registration

publication date

  • June 25, 2020

Research

keywords

  • Antihypertensive Agents
  • Atenolol
  • Atrial Fibrillation
  • Cholesterol, HDL
  • Hypertension
  • Hypertrophy, Left Ventricular
  • Losartan

Identity

Scopus Document Identifier

  • 85087142658

Digital Object Identifier (DOI)

  • 10.1080/08037051.2020.1782171

PubMed ID

  • 32586143

Additional Document Info

volume

  • 29

issue

  • 5